Company Filing History:
Years Active: 2005-2012
Title: The Innovations of Steven W. Sutton
Introduction
Steven W. Sutton is a notable inventor based in Carlsbad, CA (US). He has made significant contributions to the field of biochemistry and pharmacology, holding a total of 4 patents. His work primarily focuses on the development of chimeric polypeptides and their applications in receptor-ligand interactions.
Latest Patents
Among his latest patents, one is titled "Chimeric peptide antagonist for GPCR135 or GPCR142." This patent describes the chimeric polypeptide R3(BΔ23-27)R/I5, which serves as a high-affinity antagonist for GPCR135 and GPCR142 over LGR7. Another significant patent is "Relaxin-3 chimeric polypeptides and their preparation and use." This patent details chimeric polypeptides of relaxin-3, prepropolypeptides, polynucleotides encoding such polypeptides, and associated expression vectors and host cells. These polypeptides can be utilized to prepare receptor-ligand complexes with GPCR135 or GPCR142, which may be employed in various assay methods.
Career Highlights
Steven W. Sutton is currently associated with Janssen Pharmaceutica NV, where he continues to innovate and contribute to the field. His work has been instrumental in advancing the understanding of GPCRs and their potential therapeutic applications.
Collaborations
He has collaborated with notable colleagues such as Timothy W. Lovenberg and Chester Kuei, further enhancing the impact of his research and innovations.
Conclusion
Steven W. Sutton's contributions to the field of biochemistry through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in pharmacological research and applications.